First Turn Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-464,435
Closed -$10.9M 49
2024
Q2
$10.9M Hold
464,435
1.78% 30
2024
Q1
$17.6M Buy
+464,435
New +$17.6M 2.64% 20